Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Oct;61(10):3102-8.
doi: 10.1128/JVI.61.10.3102-3108.1987.

CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity

M J Reddehase, W Mutter, K Münch, H J Bühring, U H Koszinowski

CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity

M J Reddehase et al. J Virol. 1987 Oct.

Abstract

We have shown in a murine model system for acute, lethal cytomegalovirus (CMV) disease in the immunocompromised natural host that control of virus multiplication in tissues, protection from virus-caused tissue destruction, and survival are mediated by virus-specific CD8+ CD4-T lymphocytes. Protection from a lethal course of disease did not result in a rapid establishment of virus latency, but led to a long-lasting, persistent state of infection. The CD8- CD4+ subset of T lymphocytes was not effective by itself in controlling murine CMV (MCMV) multiplication in tissue or essential for the protective function of the CD8+ CD4- effector cells. The antiviral efficacy of the purified CD8+ CD4- subset was not impaired by preincubation with fibroblasts that presented viral structural antigens, but was significantly reduced after depletion of effector cells specific for the nonstructural immediate-early antigens of MCMV, which are specified by the first among a multitude of viral genes expressed during MCMV replication in permissive cells. Thus, MCMV disease provides the first example of a role for nonstructural herpesvirus immediate-early antigens in protective immunity.

PubMed Disclaimer

References

    1. J Virol. 1974 Jul;14(1):8-19 - PubMed
    1. Nature. 1977 Jun 23;267(5613):721-3 - PubMed
    1. J Immunol. 1979 May;122(5):1798-806 - PubMed
    1. J Exp Med. 1979 Jul 1;150(1):108-16 - PubMed
    1. J Infect Dis. 1980 Dec;142(6):816-24 - PubMed

Publication types

MeSH terms

Substances